Drugs / IDEC-159
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00102024 Background | Jan 2005 → Jan 2006 | metastasis from malignant tumor of colon | Biogen | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDEC-159 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00102024 ↗ |
| Modality | Monoclonal antibody | “90Y-Labeled IDEC-159, Humanized, Domain Deleted, Anti TAG-72 Monoclonal Antibody” NCT00102024 ↗ |